11/13/2024
7:06 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:48 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
11:55 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
3:09 PM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:12 PM | Corcept Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/03/2024
3:27 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
6:55 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/01/2024
11:55 AM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
11:44 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
5:34 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:27 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:24 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:57 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:04 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:08 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
10:33 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
4:59 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
2:37 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
6:10 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
5:31 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
5:56 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
3:42 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
12:36 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
10:26 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
3:13 PM | Corcept Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/03/2024
4:13 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:16 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:54 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:54 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
12:54 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
12:46 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
12:30 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
9:16 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
5:47 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:21 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:19 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:10 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:11 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:13 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:15 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:15 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
06/03/2024
1:15 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
1:05 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:05 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:39 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:40 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:41 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:43 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:44 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:45 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:46 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:47 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:01 PM | Corcept Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/30/2024
8:00 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
7:03 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:53 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
12:14 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
12:22 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
5:41 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:42 PM | Corcept Therapeutics (Issuer)
Murray Joshua M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:47 PM | Corcept Therapeutics (Issuer)
Park Kimberly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:25 PM | Cannon Gillian (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:25 PM | BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:28 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:30 PM | Alton Gregg H (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:08 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
7:32 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
8:32 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
11:24 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
11:35 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
7:23 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:05 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
10:39 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
4:09 PM | Corcept Therapeutics (Filer)
| Form DEFA14A | |
04/17/2024
3:44 PM | Corcept Therapeutics (Filer)
| Form ARS | |
04/17/2024
5:05 AM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
6:00 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:43 PM | Corcept Therapeutics (Filer)
| Form DEF 14A | |
04/08/2024
5:16 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
11:40 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
7:00 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:38 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
9:03 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
1:12 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
1:32 PM | Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G/A | |
03/27/2024
12:01 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:09 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:14 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
03/05/2024
8:19 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:02 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:03 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:09 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:41 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:24 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:11 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
7:06 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
11:12 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
